Results 231 to 240 of about 48,818 (277)
Some of the next articles are maybe not open access.
Osteoporosis in postmenopausal women
The Journal of Prosthetic Dentistry, 1984Eleven postmenopausal complete denture patients participated in a study to evaluate some possible predictors of osteoporosis. Most participants in the study reported a low caloric intake and consumed considerably less than the recommended daily allowances of sodium, cholesterol, calcium, fluoride, magnesium, zinc, and folic acid.
R P, Renner, L J, Boucher, H W, Kaufman
openaire +2 more sources
Management of Postmenopausal Osteoporosis
Annual Review of Medicine, 2015A hallmark of menopause, which follows the decline in the ovarian production of estrogen, is the aggressive and persistent loss of bone mineral and structural elements leading to loss of bone strength and increased fracture risk. This review focuses on newer methods of diagnosing osteoporosis and assessing fracture risk, as well as on novel management
Panagiota, Andreopoulou +1 more
openaire +2 more sources
CALCITONIN AND POSTMENOPAUSAL OSTEOPOROSIS
Clinical Endocrinology, 1984SUMMARYFasting serum calcitonin levels were measured in 54 postmenopausal women who had for 10 years been taking part in a double blind trial to assess the effect of the synthetic oestrogen, mestranol, on postmenopausal bone loss. There were no differences in calcitonin levels between mestranol treated and placebo groups, Fifteen of the women were ...
J, Leggate +5 more
openaire +2 more sources
Treatment of Postmenopausal Osteoporosis
Comprehensive Therapy, 2007Osteoporosis is a skeletal disease characterized by low bone mass and microarchitectural deterioration with a resulting increase in bone fragility and hence susceptibility to fracture. Calcium and vitamin D are the most commonly used therapies for osteoporosis, although their efficacy in osteoporotic fracture prevention remains uncertain ...
Gayatri, Gupta, Wilbert S, Aronow
openaire +2 more sources
â–¼Denosumab for postmenopausal osteoporosis?
Drug and Therapeutics Bulletin, 2012Osteoporosis is the most common clinical disorder of bone metabolism, and is characterised by low bone mass and deterioration of the microarchitecture of bone tissue that results in increased bone fragility and susceptibility to bone fracture.1 In the UK, it is estimated that osteoporosis affects over 3 million people and leads to 230,000 fractures per
openaire +2 more sources
Postmenopausal osteoporosis and alendronate
Maturitas, 2004Osteoporosis is a systemic metabolic disorder associated with a decreased bone mass and resistance. Bisphosphonates suppress bone resorption and bone turnover by a mechanism that depends on their structure. They are characterized by low gastrointestinal absorption. In postmenopausal women, alendronate (ALN) reduces bone resorption markers and increases
openaire +2 more sources
Postmenopausal osteoporosis management
Current Opinion in Obstetrics and Gynecology, 2000Osteoporosis is perhaps the widest-ranging social, physical, and economic impact of estrogen deficiency. Postmenopausal bone loss is the major determinant of osteoporosis. Osteoporotic risk can be determined by measuring bone mineral density using dual X-ray absorptiometry.
M, Gambacciani, M, Ciaponi
openaire +2 more sources
Treatment of Postmenopausal Osteoporosis
JAMA, 2001POSTMENOPAUSAL OSTEOPOROSIS IS a common and serious clinical problem. As both individuals and society have come to recognize the importance of preventing and treating osteoporosis, several new medications have been developed that have been shown to reduce fracture rates in women with osteoporosis.
D, Altkorn, T, Vokes
openaire +2 more sources
Treatment of Postmenopausal Osteoporosis
Drugs, 1979Bone loss can be prevented by standard oestrogen replacement therapy and delayed by the administration of calcium supplements. The most suitable patients to treat are those with a raised urinary hydroxyproline or other evidence of rapid bone loss. Patients aged below 65 years with established osteoporosis, and in whom oestrogens are not contraindicated,
openaire +2 more sources